首页
数据库
关于我们
联系我们
您当前的位置： 首页 > 数据库
所属年份
2008 2017 2018 2019 2020 2021 2022 2023 2024
到
2008 2017 2018 2019 2020 2021 2022 2023 2024
检索 清除
手术分类
  • 全部（1880）
  • 腹部手术（323）
  • 胸科手术（41）
  • 血管手术（5）
  • 心脏手术（56）
  • 神经外科（4）
  • 头颈部（35）
  • 骨科（78）
  • 泌尿外科（0）
  • 妇产手术（56）
  • 日间手术（26）
  • 手术室外（0）
  • 创伤和烧伤（0）
  • 非心脏手术（410）
  • 老年（0）
  • 小儿新生儿（126）
  • 特殊患者（42）
  • 未说明手术类型（678）
阶段管理
  • 术前宣教（21）
  • 术前评估（33）
  • 术前用药（15）
  • 术前禁食水（12）
  • 麻醉选择（21）
  • 麻醉用药（10）
  • 术中监测（23）
  • 液体管理（14）
  • 血液保护（3）
  • 体温管理（8）
  • 术后疼痛（43）
  • POD（8）
  • PONV（10）
  • 术后康复（50）
  • 特殊情况（43）
  • 术前肠道准备（9）
排序：
发表时间 阅读量
Array ( [id] => 2184 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2184.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => It is recommended that patients with HF undergoing NCS receive optimal medical treatment according to current ESC guidelines.(Evidence: Level A ，Recommendation: Class I) [laiyuan] => 对合并HF拟行NCS患者的药物治疗，建议参考当前ESC的有关指南。（证据级别：A；推荐强度：I） [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
对合并HF拟行NCS患者的药物治疗，建议参考当前ESC的有关指南。（证据级别：A；推荐强度：I）

It is recommended that patients with HF undergoing NCS receive optimal medical treatment according to current ESC guidelines.(Evidence: Level A ，Recommendation: Class I)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2185 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2185.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => n patients with HF undergoing NCS, it is recommended to regularly assess volume status and signs of organ perfusion.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 合并HF拟行NCS 的患者，建议持续评估其容量状态及脏器灌注情况。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
合并HF拟行NCS 的患者，建议持续评估其容量状态及脏器灌注情况。（证据级别：C；推荐强度：I）

n patients with HF undergoing NCS, it is recommended to regularly assess volume status and signs of organ perfusion.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2186 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2186.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => A multidisciplinary team including VAD specialists is recommended for peri-operative management of patients with HF receiving mechanical circulatory support.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 建 议 组 建 包 括 心 室 辅 助 装 置 （ventricular assist device, VAD）专家在内的围术期多学科团队治疗因HF而行机械循环支持的患者。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
建 议 组 建 包 括 心 室 辅 助 装 置 （ventricular assist device, VAD）专家在内的围术期多学科团队治疗因HF而行机械循环支持的患者。（证据级别：C；推荐强度：I）

A multidisciplinary team including VAD specialists is recommended for peri-operative management of patients with HF receiving mechanical circulatory support.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2187 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2187.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Clinical and echocardiographic evaluation (if not recently performed) is recommended in all patients with known or suspected VHD who are scheduled for elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 建议对所有已知或疑似心脏瓣膜病且计划接受择期高风险或中风险非心脏手术的患者进行临床评估和超声心动图检查（如未近期进行）。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
建议对所有已知或疑似心脏瓣膜病且计划接受择期高风险或中风险非心脏手术的患者进行临床评估和超声心动图检查（如未近期进行）。（证据级别：C；推荐强度：I）

Clinical and echocardiographic evaluation (if not recently performed) is recommended in all patients with known or suspected VHD who are scheduled for elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2188 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2188.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => AVR (SAVR or TAVI) is recommended in symptomatic patients with severe AS who are scheduled for elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 对于计划接受择期高危或中危非心脏手术的重度主动脉瓣狭窄（手术主动脉瓣置换术或经导管主动脉瓣植入术）症状患者，推荐使用主动脉瓣置换术。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
对于计划接受择期高危或中危非心脏手术的重度主动脉瓣狭窄（手术主动脉瓣置换术或经导管主动脉瓣植入术）症状患者，推荐使用主动脉瓣置换术。（证据级别：C；推荐强度：I）

AVR (SAVR or TAVI) is recommended in symptomatic patients with severe AS who are scheduled for elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2189 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2189.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In asymptomatic patients with severe AS who are scheduled for elective high-risk NCS, AVR (SAVR or TAVI) should be considered after Heart Team discussion.(Evidence: Level C，Recommendation: Class IIa) [laiyuan] => 对于症状不明显但病情严重的主动脉夹层患者，在心脏团队讨论后，应考虑进行选择性高风险非心脏手术（如手术主动脉瓣置换术或经导管主动脉瓣植入术）。（证据级别：C；推荐强度：IIa） [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
对于症状不明显但病情严重的主动脉夹层患者，在心脏团队讨论后，应考虑进行选择性高风险非心脏手术（如手术主动脉瓣置换术或经导管主动脉瓣植入术）。（证据级别：C；推荐强度：IIa）

In asymptomatic patients with severe AS who are scheduled for elective high-risk NCS, AVR (SAVR or TAVI) should be considered after Heart Team discussion.(Evidence: Level C，Recommendation: Class IIa)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2190 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2190.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with severe symptomatic AS in need of time-sensitive NCS or in whom the TAVI and SAVR are unfeasible, BAV may be considered before NCS as a bridge to definitive aortic valve repair.(Evidence: Level C ，Recommendation: Class IIb) [laiyuan] => 对于患有严重症状性主动脉瓣狭窄且需要紧急非心脏手术，或者经导管主动脉瓣植入术和外科主动脉瓣置换术均不可行的患者，在非心脏手术前可考虑将球囊主动脉瓣成形术作为最终主动脉瓣修复的过渡手段。（证据级别：C；推荐强度：IIb） [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
对于患有严重症状性主动脉瓣狭窄且需要紧急非心脏手术，或者经导管主动脉瓣植入术和外科主动脉瓣置换术均不可行的患者，在非心脏手术前可考虑将球囊主动脉瓣成形术作为最终主动脉瓣修复的过渡手段。（证据级别：C；推荐强度：IIb）

In patients with severe symptomatic AS in need of time-sensitive NCS or in whom the TAVI and SAVR are unfeasible, BAV may be considered before NCS as a bridge to definitive aortic valve repair.(Evidence: Level C ，Recommendation: Class IIb)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2191 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2191.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with symptomatic severe AR or asymptomatic severe AR and LVESD .50 mm or LVESDi (LVESD/BSA) .25 mm/m2 (in patients with small body size) or resting LVEF ≤50%, valve surgery is recommended prior to elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 对于有症状的严重主动脉瓣反流或无症状的严重主动脉瓣反流以及左室舒张末期内径≥50 mm或左室舒张末期内径与体质指数的比值≥0.25 mm/m2（对于体型较小的患者）或静息状态下左室射血分数≤50%的患者，建议在选择性高危非心脏手术前进行瓣膜手术。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
对于有症状的严重主动脉瓣反流或无症状的严重主动脉瓣反流以及左室舒张末期内径≥50 mm或左室舒张末期内径与体质指数的比值≥0.25 mm/m2（对于体型较小的患者）或静息状态下左室射血分数≤50%的患者，建议在选择性高危非心脏手术前进行瓣膜手术。（证据级别：C；推荐强度：I）

In patients with symptomatic severe AR or asymptomatic severe AR and LVESD .50 mm or LVESDi (LVESD/BSA) .25 mm/m2 (in patients with small body size) or resting LVEF ≤50%, valve surgery is recommended prior to elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2192 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2192.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with moderate-to-severe rheumatic MS and symptoms or SPAP .50 mmHg, valve intervention (PMC or surgery) is recommended before elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 对于中至重度风湿性多发性硬化症患者以及有症状或中心静脉压达到50 mmHg的患者，建议在选择性高风险非心脏手术之前进行瓣膜干预（经皮二尖瓣裂切开术或手术）。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
对于中至重度风湿性多发性硬化症患者以及有症状或中心静脉压达到50 mmHg的患者，建议在选择性高风险非心脏手术之前进行瓣膜干预（经皮二尖瓣裂切开术或手术）。（证据级别：C；推荐强度：I）

In patients with moderate-to-severe rheumatic MS and symptoms or SPAP .50 mmHg, valve intervention (PMC or surgery) is recommended before elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2193 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2193.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with symptomatic severe primary MR or asymptomatic severe primary MR with LV dysfunction (LVESD ≥40 mm and/or LVEF ≤60%), valve intervention (surgical or transcatheter) should be considered prior to intermediate- or high-risk NCS, if time allows.(Evidence: Level C，Recommendation: Class IIa) [laiyuan] => 对于有症状的重度原发性二尖瓣反流或无症状但有左室功能障碍（左心室收缩末期直径≥40mm和/或左心室射血分数≤60%）的患者，如果时间允许，应考虑在进行中高风险非心脏手术之前进行瓣膜干预（外科手术或经导管）。（证据级别：C；推荐强度：IIa） [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
对于有症状的重度原发性二尖瓣反流或无症状但有左室功能障碍（左心室收缩末期直径≥40mm和/或左心室射血分数≤60%）的患者，如果时间允许，应考虑在进行中高风险非心脏手术之前进行瓣膜干预（外科手术或经导管）。（证据级别：C；推荐强度：IIa）

In patients with symptomatic severe primary MR or asymptomatic severe primary MR with LV dysfunction (LVESD ≥40 mm and/or LVEF ≤60%), valve intervention (surgical or transcatheter) should be considered prior to intermediate- or high-risk NCS, if time allows.(Evidence: Level C，Recommendation: Class IIa)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读

地址：甘肃省兰州市七里河区瓜州路418号

邮编：730050

电话：0931-2687109

商务合作热线：0931-2687106

备案号：陇ICP备17005383号-1 联网备案号：62010302000288

技术支持：瑞秀科技